Posted by Michael Wonder on 28 May 2019
1500 New Zealanders access a cure for hepatitis C
27 May 2019 - Over 1500 New Zealanders have started a new hepatitis C treatment in the last three months that could dramatically change their lives.
Since 1 February this year, anyone diagnosed with hepatitis C has become eligible to receive a PHARMAC funded medicine to treat Hepatitis C called Maviret.
Lyneese Dunshea, a 52-year-old Auckland mother of two, completed her 12-week course of Maviret last month. It has been life changing for her.
